Shares of Elevai Labs, Inc. (NASDAQ:ELAB – Get Free Report) were up 5.1% during trading on Wednesday . The company traded as high as $4.73 and last traded at $4.55. Approximately 55,136 shares traded hands during mid-day trading, a decline of 59% from the average daily volume of 136,076 shares. The stock had previously closed at $4.33.
Elevai Labs Price Performance
The company’s fifty day moving average is $8.94 and its two-hundred day moving average is $53.30. The company has a debt-to-equity ratio of 0.06, a quick ratio of 3.40 and a current ratio of 3.86. The firm has a market cap of $2.63 million, a price-to-earnings ratio of -0.07 and a beta of -2.95.
About Elevai Labs
Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021.
Read More
- Five stocks we like better than Elevai Labs
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- The 3 Most Talked About Investments on WallStreetBets Right Now
- How to Plot Fibonacci Price Inflection Levels
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Elevai Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevai Labs and related companies with MarketBeat.com's FREE daily email newsletter.
